Investment Summary

Accelmed Invests In Click Therapeutics

On October 22, 2021, private equity firm Accelmed invested in software company Click Therapeutics

Investment Highlights
  • This is Accelmed’s 1st transaction in the Software sector.
  • This is Accelmed’s 11th transaction in the United States.
  • This is Accelmed’s 3rd transaction in New York.

Investment Summary
Date 2021-10-22
Target Click Therapeutics
Sector Software
Investor(s) Accelmed
Deal Type Venture

Target

Click Therapeutics

New York, New York, United States
Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click Therapeutics was founded in 2012 and is based in New York, New York.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Accelmed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2009
Size Small
Type Sector Focused
DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.

DEAL STATS #
Overall 15 of 18
Sector (Software) 1 of 1
Type (Venture) 8 of 8
State (New York) 3 of 3
Country (United States) 11 of 14
Year (2021) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-16 Veranex

Raleigh, North Carolina, United States

Veranex is a comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance for each of its four concept-through-commercialization pillars: engineering and design, clinical, market access, and regulatory. The company enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, its customers realize efficiencies in cost and time, while its comprehensive solutions unify the entire development process. Veranex is based in Raleigh, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-14 SKNV

Pompano Beach, Florida, United States

SKNV is a pioneer in customized medications and skincare solutions for dermatology practices across the United States. Combining a fully integrated, in-office dispensing solution for local doctors with a digital health ecommerce platform for monthly patient refills, SKNV places the power to determine and fully manage customized prescription care paths back in the hands of local providers. The SKNV Customized Dermatology System delivers targeted results and repeat purchases through tailored regimens in preventative, curative, and maintenance skin care. SKNV is based in Pompano Beach, Florida.

Buy -
Mergr

Product

Company

Legal